Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial. (October 2022) - Yamada, Hideto; Deguchi, Masashi; Saito, Shigeru; Takeshita, Toshiyuki